People with MS who have mild disability still experience disease-related difficulties at work, a new study found, calling for ...

A generic version of multiple sclerosis drug Copaxone was introduced in 2015, but it has done little to lower drug costs for MS patients, NPR reported. Yearly costs for MS drugs can run as high as $50 ...

The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...

—Clinicians may be underestimating the cognitive burden on patients with MS, underscoring the need for more comprehensive cognitive assessments and assessing patient-reported outcomes. A growing body ...

MS is an autoimmune disorder in which the immune system attacks myelin, the protective covering of nerve fibres in the brain ...

The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...

“This study found that having bladder problems was significantly associated with lower well-being in [people with] MS, particularly when considering OAB. Bowel problems, self-management of bladder ...

BUFFALO, N.Y. — In recent years, new drugs to treat multiple sclerosis have significantly improved both the quality of life and longevity for patients with MS. Many of them now live well into their ...

A new study found smoking cannabis reduced spasticity in MS patients. May 14, 2012— -- Smoking marijuana may reduce certain symptoms in patients with multiple sclerosis, according to a new small ...